F. Society and . Dermatology, Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. Guidelines, Ann Dermatol V en er eol, vol.136, pp.177-86, 2009.

J. Albores-saavedra, K. Batich, and F. Chable-montero, Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study, J Cutan Pathol, vol.37, pp.20-27, 2010.

L. Borradori, B. Sutton, P. Shayesteh, and G. A. Daniels, Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases, Br J Dermatol, vol.175, pp.1382-1388, 2016.

V. Blum, B. M?-uller, and S. Hofer, Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases, Eur J Dermatol EJD, vol.28, pp.78-81, 2018.

E. Degache, J. Crochet, and N. Simon, Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma, J Eur Acad Dermatol Venereol, vol.32, pp.257-265, 2018.

A. Chen, N. Ali, P. Boasberg, and A. Ho, Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab, J Clin Med, vol.7, p.10, 2018.

M. R. Migden, D. Rischin, and C. D. Schmults, PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma, N Engl J Med, vol.379, pp.341-51, 2018.

P. T. Nghiem, S. Bhatia, E. J. Lipson, and R. R. Kudchadkar, PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma, N Engl J Med, vol.374, pp.2542-52, 2016.

S. L. Topalian, S. Bhatia, and A. Hollebecque, Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC), Cancer Res, vol.77, pp.74-074, 2017.

H. L. Kaufman, J. S. Russell, and O. Hamid, Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ?1 year of follow-up: JAVELIN Merkel